Ongoing complete response after treatment cessation with dabrafenib, trametinib, and cetuximab as third-line treatment in a patient with advanced BRAF(V600E) mutated, microsatellit...

por Piringer, Gudrun, Decker, Jörn, Trommet, Vera, Kühr, Thomas, Heibl, Sonja, Dörfler, Konrad, Thaler, Josef
Publicado 2023